| 000 | 02606cam a2200409 i 4500 | ||
|---|---|---|---|
| 005 | 20250919124751.0 | ||
| 008 | 181002t20172017flua b 001 0 eng | ||
| 020 |
_a9781498725323 (hardback : alk. paper) _cRM908.86 |
||
| 020 | _a1498725325 (hardback : alk. paper) | ||
| 039 | 9 |
_a201810111123 _bfida _y10-02-2018 _zruzini |
|
| 040 |
_aDNLM/DLC _beng _cDLC _erda _dDLC _dUKM _erda |
||
| 060 | 1 | 0 |
_aQT36.5 _b.S587 2017 9 |
| 090 | _aQT36.5.S587 2017 9 | ||
| 245 | 0 | 0 |
_aSilver nanoparticles for antibacterial devices : _bbiocompatibility and toxicity / _c[edited by] Huiliang Cao. |
| 264 | 1 |
_aBoca Raton : _bCRC Press, Taylor & Francis Group, _c[2017]. |
|
| 264 | 4 | _c©2017. | |
| 300 |
_axiv, 463 pages : _billustrations (some color) ; _c24 cm. |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aBioinspired synthesis of silver nanoparticles : characterization, mechanism, and applications -- Tuning the properties of silver monolayer for biological applications -- Synergistic antimicrobial activity of silver and chitosan -- Titania nanotubes as silver nanoparticle carriers to prevent implant-associated infection -- Polymer-silver nanocomposites : preparation, characterization, and antibacterial mechanism -- Dissolution of silver nanoparticles -- Silver as an antimicrobial agent : the resistance issue -- The risks of silver nanoparticles to human body -- Imunomodulatory activities of silver nanoparticles (Ag NPs) in human neutrophils -- Evaluating the interactions of silver nanoparticles and mammalian cells based on biomices technologies -- Methods and tools for assessing nanomaterials and uses and regulation of nanosilver in Europe -- Toward selectively toxic silver nanoparticles -- Orthopaedic implant-associated infections : pathogenesis, clinical presentation and management -- Dental implant infection : typical causes and control -- Guidelines for nanosilver-based antibacterial devices. | |
| 650 | 2 | _aNanoparticles. | |
| 650 | 2 | _aSilver. | |
| 650 | 2 |
_aBiocompatible Materials _xtoxicity. |
|
| 650 | 2 | _aAnti-infective agents. | |
| 650 | 2 |
_aNanoparticles _xtherapeutic use. |
|
| 700 | 1 |
_aCao, Huiliang, _eeditor. |
|
| 907 |
_a.b16626096 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQT36.5.S587 2017 9 |
||
| 914 | _avtls003637825 | ||
| 990 | _afn/ | ||
| 991 | _aFakulti Farmasi, KKL | ||
| 998 |
_ad _b2018-02-10 _cm _da _feng _gflu _y0 _z.b16626096 |
||
| 999 |
_c630908 _d630908 |
||